Ill-Defined Outcomes – Results of a Research Study on Downside Mitigation ETFs
2022 provided a litmus test for ETFs designed to shield Investors from the full impact of a major stock market decline. The bad news is that half of them failed. The good news is that three of them actually did perform in line with their objectives. These are the results of a recent study that I co-authored … Read more